Clinical trial

Azilsartan in Chinese Patients With Mild and Moderate Hypertension

NCT02609490

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-01

PhasePHASE3

Study timeline

Study start (actual)2015-09-01Date precision: month

Registry last updated2018-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Azilsartan tabletsDRUG

Azilsartan placebo tabletsDRUG

Olmesartan medoxomil tabletsDRUG

olmesartan medoxomil placebo tabletsDRUG

Sponsors & collaborators

Lee's Pharmaceutical Limitedlead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02609490 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.